Insider · CIK 0002068849
Andrew Walsh
Files at ANVS (Annovis Bio, Inc.). First filing -, latest -.
In brief
Andrew Walsh files SEC Form 4 as officer at ANVS (Annovis Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Andrew Walsh has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | ANVS Annovis Bio, Inc. | AGrant or award Common Stock | +500 | $2.90 | $1,450 | 500 | Jun 18, 2025 |
Questions about Andrew Walsh
Answered from the filings on this page, as of the latest one.
Is Andrew Walsh buying or selling?
Andrew Walsh has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Andrew Walsh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew Walsh has 0.
Where does Andrew Walsh file Form 4?
Andrew Walsh has filed Form 4 at ANVS (Annovis Bio, Inc.) as Vice President, Finance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.